The study carried out by Tsung et al. reported the methylation status of the Hey1 factor and its contribution to GBM pathogenesis, and they found low levels of CpG methylation when compared with a healthy brain owing to the overexpression of Hey1 [118]. The gene discussed is HEY1; the disease is glioblastoma.